NCT02381886 2025-11-10A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 MutationsNovartisPhase 1 Active not recruiting166 enrolled
NCT03452774 2025-10-28SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryMassive Bio, Inc.Recruiting50,000 enrolled
NCT02711137 2025-10-21Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated137 enrolled 31 charts
NCT02649790 2025-03-19Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer IndicationsKaryopharm Therapeutics IncPhase 1/2 Completed277 enrolled
NCT02498665 2023-11-14A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced MalignanciesSumitomo Pharma America, Inc.Phase 1 Completed24 enrolled
NCT02431260 2019-06-14An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated69 enrolled 34 charts